Association between contrast extravasation on computed tomography scans and pseudoaneurysm formation in pediatric blunt splenic and hepatic injury: A multi-institutional observational study
jpedsurg.org shows its articles on its own site.
Read the article on jpedsurg.org ↗Article · Jul 2019 · 1 min read
In brief
In brief
Multi-institutional study of 236 pediatric blunt liver/spleen injuries found contrast extravasation on initial CT independently predicts pseudoaneurysm formation (OR 4.96), regardless of injury grade. Findings support selective follow-up imaging in children with contrast extravasation to enable early pseudoaneurysm detection during nonoperative management.
Written by the GCMD Library team from the article.
Purpose
We aimed to examine the association between contrast extravasation (CE) on initial computed tomography (CT) scan and pseudoaneurysm (PSA) development in pediatric blunt splenic and/or liver injury.
Methods
We conducted a multi-institutional retrospective study in cases of blunt splenic and/or hepatic injury who underwent an initial attempt of nonoperative management. A logistic regression model was used to compare PSA formation and CE on initial CT scan, and the area under the receiver operating characteristic curve (AUC) with and without CE was used to assess the predictive performance of CE for PSA formation.
Results
Of 236 cases enrolled from 10 institutions, PSA formation was observed in 17 (7.2%). Multivariate analysis showed a significant association between CE on initial CT scan and increased incidence of PSA formation (odds ratio, 4.96; 95% confidence interval, 1.37–18.0). There was no statistically significant association between the grade of injury and PSA formation. The AUC improved from 0.75 (0.64–0.87) to 0.80 (0.70–0.91) with CE.
Conclusion
Active CE on initial CT scan was an independent predictor of PSA formation. Selective use of follow-up CT in children who showed CE on initial CT may provide early identification of PSA formation, regardless of injury grade.
Level of evidence
Prognostic and epidemiological, level III.